OpenVSafe by OpenVAERS
Search V-safe

TUD-33268-96380

2 vaccinations 1 coded response 13 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
191 / PA
Registered
2020-12-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-19
    Registered in v-safe
  2. 2020-12-19
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-19
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · None
    Adult check-in
  4. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  5. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-01-04
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  7. 2021-01-11
    Dose 2 — Pfizer-BioNTech
  8. 2021-01-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-01-12
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  10. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches
    Adult check-in
  11. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache
    Adult check-in
  12. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  14. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-01-26
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-02-24
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-07-12
    Survey response — 6 months, dose 2
    MedDRA: Abortion spontaneous, Pregnancy, Premature labour — Feeling: Good · Be unable to work or attend school
    Free text: Preterm labor resulting in pregnancy loss
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-19Pfizer-BioNTech
22021-01-11Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-01-12 priority 2/3

Free text

Release 9 — 6 months, dose 2

2021-07-12

Symptoms: Preterm labor resulting in pregnancy loss

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbortion spontaneous ✓ ✓ ✓
SDPregnancy ✓ ✓ ✓
SDPremature labour ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release